These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10771973

  • 1. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia.
    Pappagallo M, Abbasi S, Bhutani VK.
    Indian J Pediatr; 1998; 65(2):273-82. PubMed ID: 10771973
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
    Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C.
    Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
    [Abstract] [Full Text] [Related]

  • 3. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
    Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH.
    Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536
    [Abstract] [Full Text] [Related]

  • 4. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E, Bauer S, Alberti C, Jonville-Béra AP, Aujard Y, Bensouda-Grimaldi L, Baud O.
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL, Patterson CC, Halahakoon CW, European Multicenter Steroid Study Group.
    Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
    [Abstract] [Full Text] [Related]

  • 6. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D.
    Neonatology; 2015 Feb; 107(4):358-9. PubMed ID: 26044104
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
    Brundage KL, Mohsini KG, Froese AB, Walker CR, Fisher JT.
    Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
    [Abstract] [Full Text] [Related]

  • 8. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL, Mettelman BB, Bode MM, Gross SJ.
    J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Kugelman A, Durand M, Garg M.
    Pediatrics; 1997 Jan; 99(1):71-5. PubMed ID: 8989341
    [Abstract] [Full Text] [Related]

  • 10. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 11. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS, Ohlsson A, Halliday H, Shah VS.
    Cochrane Database Syst Rev; 2003 Mar; (2):CD002057. PubMed ID: 12804423
    [Abstract] [Full Text] [Related]

  • 12. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS.
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [Abstract] [Full Text] [Related]

  • 13. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J, Beedgen B, Böhler T, Sontheimer D, Zilow EP, Linderkamp O.
    Klin Padiatr; 1996 Aug; 208(2):56-60. PubMed ID: 8901183
    [Abstract] [Full Text] [Related]

  • 14. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome.
    Tapia JL, Ramírez R, Cifuentes J, Fabres J, Hübner ME, Bancalari A, Mercado ME, Standen J, Escobar M.
    J Pediatr; 1998 Jan; 132(1):48-52. PubMed ID: 9469999
    [Abstract] [Full Text] [Related]

  • 15. Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates.
    Pai VB, Nahata MC.
    Ann Pharmacother; 2000 Mar; 34(3):386-92. PubMed ID: 10917388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 18. The use of inhaled glucocorticosteroids and recovery from adrenal suppression after systemic steroid use in a VLBW premature infant with BPD: case report and literature discussion.
    Karinski DA, Balkundi D, Rubin LP, Padbury JF.
    Neonatal Netw; 2000 Dec; 19(8):27-32. PubMed ID: 11949271
    [Abstract] [Full Text] [Related]

  • 19. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
    Ballabh P, Kumari J, Krauss AN, Shin JJ, Jain A, Auld PA, Lesser ML, Cunningham-Rundles S.
    Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.